The National Institutes of Health today urged scientists and inventors with a rapid testing technology to compete for a share of $500 million in funding to develop accurate at-home and point-of-care diagnostic tests, with the goal to make millions of tests available per week by the end of summer and even more in time for the flu season.

“We need American tech experts, innovators and entrepreneurs to step up to one of the toughest challenges we’ve faced as a country, to help get us safely back to public spaces,” said Bruce Tromberg, director of the National Institute of Biomedical Imaging and Bioengineering.

The challenge is part of a new NIH Rapid Acceleration of Diagnostics (RADx) initiative that will invest $1.5 billion in funding from the Paycheck Protection Program and Health Care Enhancement Act in early innovative testing technologies. RADx will expand an NIBIB Point-of-Care Technologies Research Network that supports innovators through technology hubs at Emory University/Georgia Institute of Technology; Johns Hopkins University; Northwestern University; University of Massachusetts Medical School; and the Consortia for Improving Medicine with Innovation & Technology at Harvard Medical School/Massachusetts General Hospital.

Related News Articles

Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…